Eelen G, Treps L, Li X, Carmeliet P. Basic and therapeutic aspects of angiogenesis updated. Circ Res. 2020;127:310–29. https://doi.org/10.1161/CIRCRESAHA.120.316851.

Article  CAS  PubMed  Google Scholar 

Giacca M, Zacchigna S. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther. 2012;19:622–9. https://doi.org/10.1038/gt.2012.17.

Article  CAS  PubMed  Google Scholar 

Cappelletto A, Zacchigna S. Cardiac revascularization: state of the art and perspectives. Vasc Biol. 2019;1:H47–51. https://doi.org/10.1530/VB-19-0011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wazan LE, Widhibrata A, Liu GS. Soluble FLT-1 in angiogenesis: pathophysiological roles and therapeutic implications. Angiogenesis. 2024. https://doi.org/10.1007/s10456-024-09942-8.

Article  PubMed  Google Scholar 

Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990;5:519–24.

CAS  PubMed  Google Scholar 

Shibuya M. Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:167–78. https://doi.org/10.2183/pjab.87.167.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9:225–30. https://doi.org/10.1007/s10456-006-9055-8.

Article  CAS  PubMed  Google Scholar 

Alvarez-Palomo B, Barrot-Feixat C, Sarret H, Requena J, Pau M, Vidal-Taboada JM, Oliva R, Ballesca JL, Edel MJ, Mezquita-Pla J. Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases. Oncotarget. 2019;10:5871–87. https://doi.org/10.18632/oncotarget.27232.

Article  PubMed  PubMed Central  Google Scholar 

Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A. 1998;95:9349–54. https://doi.org/10.1073/pnas.95.16.9349.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993;90:10705–9. https://doi.org/10.1073/pnas.90.22.10705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orecchia A, Lacal PM, Schietroma C, Morea V, Zambruno G, Failla CM. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J Cell Sci. 2003;116:3479–89. https://doi.org/10.1242/jcs.00673.

Article  CAS  PubMed  Google Scholar 

Cai J, Qi X, Kociok N, Skosyrski S, Emilio A, Ruan Q, Han S, Liu L, Chen Z, Bowes Rickman C, et al. β‐Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol Med. 2012;4:980–91. https://doi.org/10.1002/emmm.201101084.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Markovic-Mueller S, Stuttfeld E, Asthana M, Weinert T, Bliven S, Goldie KN, Kisko K, Capitani G, Ballmer-Hofer K. Structure of the full-length VEGFR-1 extracellular domain in complex with VEGF-A. Structure. 2017;25:341–52. https://doi.org/10.1016/j.str.2016.12.012.

Article  CAS  PubMed  Google Scholar 

Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis. 2007;38:258–68. https://doi.org/10.1016/j.bcmd.2006.12.003.

Article  CAS  PubMed  Google Scholar 

Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016;17:611–25. https://doi.org/10.1038/nrm.2016.87.

Article  CAS  PubMed  Google Scholar 

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 1996;7:213–21.

CAS  PubMed  Google Scholar 

Chakraborty MP, Das D, Mondal P, Kaul P, Bhattacharyya S, Kumar Das P, Das R. Molecular basis of VEGFR1 autoinhibition at the plasma membrane. Nat Commun. 2024;15:1346. https://doi.org/10.1038/s41467-024-45499-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359–71. https://doi.org/10.1038/nrm1911.

Article  CAS  PubMed  Google Scholar 

Saito T, Takeda N, Amiya E, Nakao T, Abe H, Semba H, Soma K, Koyama K, Hosoya Y, Imai Y, et al. VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing. FEBS Lett. 2013;587:2179–85. https://doi.org/10.1016/j.febslet.2013.05.038.

Article  CAS  PubMed  Google Scholar 

Ito N, Wernstedt C, Engstrom U, Claesson-Welsh L. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J Biol Chem. 1998;273:23410–8. https://doi.org/10.1074/jbc.273.36.23410.

Article  CAS  PubMed  Google Scholar 

Cudmore MJ, Hewett PW, Ahmad S, Wang KQ, Cai M, Al-Ani B, Fujisawa T, Ma B, Sissaoui S, Ramma W, et al. The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis. Nat Commun. 2012;3:972. https://doi.org/10.1038/ncomms1977.

Article  CAS  PubMed  Google Scholar 

Zhang Z, Zhou B. Accelerated coronary angiogenesis by vegfr1-knockout endocardial cells. PLoS One. 2013;8:e70570. https://doi.org/10.1371/journal.pone.0070570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–83. https://doi.org/10.1056/NEJMoa031884.

Article  CAS  PubMed  Google Scholar 

Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006;443:993–7. https://doi.org/10.1038/nature05249.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Failla CM, Carbo M, Morea V. Positive and negative regulation of angiogenesis by soluble vascular endothelial growth factor receptor-1. Int J Mol Sci. 2018; 19. https://doi.org/10.3390/ijms19051306.

Article  CAS  Google Scholar 

Colotti G, Failla CM, Lacal PM, Ungarelli M, Ruffini F, Di Micco P, Orecchia A, Morea V. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1. FEBS J. 2022;289:183–98. https://doi.org/10.1111/febs.16119.

Article  CAS  PubMed  Google Scholar 

Soro S, Orecchia A, Morbidelli L, Lacal PM, Morea V, Ballmer-Hofer K, Ruffini F, Ziche M, D’Atri S, Zambruno G, et al. A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin. Blood. 2008;111:3479–88. https://doi.org/10.1182/blood-2007-03-077537.

Article  CAS  PubMed